Stryker (SYK) Cost of Revenue (2009 - 2026)
Stryker (SYK) posted quarterly Cost of Revenue of $2.1 billion for Q2 2026, down 4.13% year-over-year from $2.2 billion in Q2 2025, and down 5.38% on a QoQ basis from $2.2 billion in Q1 2026.
Stryker (SYK) Cost of Revenue (2009 - 2026) Analysis & Trends
Stryker has reported Cost of Revenue for 18 years, with the latest figure at $2.1 billion in Q2 2026.
- Cost of Revenue for Q2 2026 came in at $2.1 billion, down 4.13% year-over-year; the trailing twelve-month figure through Jun 2026 was $9.0 billion (up 5.94% YoY), and the FY2025 annual result was $9.1 billion, up 10.99% from the prior year.
- Cost of Revenue declined to $2.1 billion in Q2 2026, from $2.2 billion in the prior quarter.
- Over five years, Cost of Revenue peaked at $2.5 billion in Q4 2025 and troughed at $1.5 billion in Q1 2022.
- A 5-year average of $2.0 billion and a median of $2.0 billion in 2024 frame the typical range for Cost of Revenue.
- The widest annual swing landed in 2022, when Cost of Revenue gained 18.72%; it then fell 4.13% in 2026.
- A 5-year view of Cost of Revenue shows it stood at $2.0 billion in 2022, then grew by 7.43% to $2.1 billion in 2023, then advanced by 7.1% to $2.3 billion in 2024, then increased by 12.42% to $2.5 billion in 2025, then retreated by 17.77% to $2.1 billion in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $2.1 billion in Q2 2026, $2.2 billion in Q1 2026, and $2.5 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 635.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.09 Bn |
| Jun 30, 2026 | 2.09 Bn |
| Mar 31, 2026 | 2.21 Bn |
| Mar 31, 2026 | 2.21 Bn |
| Dec 31, 2025 | 2.54 Bn |
| Dec 31, 2025 | 2.54 Bn |
| Sep 30, 2025 | 2.21 Bn |
| Sep 30, 2025 | 2.21 Bn |
| Jun 30, 2025 | 2.18 Bn |
| Jun 30, 2025 | 2.18 Bn |
| Mar 31, 2025 | 2.12 Bn |
| Mar 31, 2025 | 2.12 Bn |
| Dec 31, 2024 | 2.26 Bn |
| Dec 31, 2024 | 2.26 Bn |
| Sep 30, 2024 | 1.98 Bn |
| Sep 30, 2024 | 1.98 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Mar 31, 2024 | 1.91 Bn |